Cargando…

Circulating levels of testosterone, 17 beta-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients.

Serum testosterone, 17 beta-oestradiol, luteinising hormone (LH) and prolactin were measured in 28 postmenopausal breast cancer patients after mastectomy and in 30 postmenopausal normal controls. In the patient group, mean levels of oestradiol, LH and prolactin did not differ significantly from thos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Secreto, G., Recchione, C., Cavalleri, A., Miraglia, M., Dati, V.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1983
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011282/ https://www.ncbi.nlm.nih.gov/pubmed/6824571

Ejemplares similares

Oestradiol-17 beta and prolactin levels in rat peripheral plasma.
por: Hawkins, R. A., et al.
Publicado: (1975)

Serum oestradiol-17 beta, testosterone, luteinizing hormone and follicle-stimulating hormone in males with breast cancer.
por: Ribeiro, G. G., et al.
Publicado: (1980)

Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630.
por: Plowman, P. N., et al.
Publicado: (1986)

A Randomised Comparison Evaluating Changes in Bone Mineral Density in Advanced Prostate Cancer: Luteinising Hormone-releasing Hormone Agonists Versus Transdermal Oestradiol
por: Langley, Ruth E., et al.
Publicado: (2016)

Oestradiol-17β plasma concentrations after intramuscular injection of oestradiol benzoate or oestradiol cypionate in llamas (Lama glama)
por: Cavilla, María V, et al.
Publicado: (2010)

Measuring luteinising hormone pulsatility with a robotic aptamer-enabled electrochemical reader
por: Liang, Shaolin, et al.
Publicado: (2019)

Hypothalamic effects of progesterone on regulation of the pulsatile and surge release of luteinising hormone in female rats
por: He, Wen, et al.
Publicado: (2017)

24-hour changes in circulating prolactin, follicle-stimulating hormone, luteinizing hormone and testosterone in male rats subjected to social isolation
por: Esquifino, Ana I, et al.
Publicado: (2004)

Use of luteinising hormone-releasing hormone agonist (leuprorelin) in advanced post-menopausal breast cancer: clinical and endocrine effects.
por: Crighton, I. L., et al.
Publicado: (1989)

Serum Oestradiol-17β in Normal Women
por: England, P. C., et al.
Publicado: (1974)

Biosynthesis of 17beta-oestradiol in human breast carcinoma tissue and a novel method for its characterization.
por: Adams, J. B., et al.
Publicado: (1975)

Proceedings: Serum oestradiol 17 beta in normal premenopausal women and in patients with benign and malignant breast disease.
por: Skinner, L. G., et al.
Publicado: (1974)

A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology
por: Ezcurra, Diego, et al.
Publicado: (2014)

Is paternal oxytocin an oxymoron? Oxytocin, vasopressin, testosterone, oestradiol and cortisol in emerging fatherhood
por: Bakermans-Kranenburg, Marian J., et al.
Publicado: (2022)

Effect of insulin-like growth factor system on luteinising angiogenesis
por: Nwachukwu, Chinwe U, et al.
Publicado: (2023)

Protective effects of D-Trp6-luteinising hormone-releasing hormone microcapsules against cyclophosphamide-induced gonadotoxicity in female rats.
por: Bokser, L., et al.
Publicado: (1990)

The effect of testosterone, dihydrotestosterone and oestradiol on the re-initiation of spermatogenesis in the adult photoinhibited Djungarian hamster
por: Meachem, Sarah J, et al.
Publicado: (2007)

Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy
por: Angus, Lachlan, et al.
Publicado: (2019)

Androgen receptors and serum testosterone levels identify different subsets of postmenopausal breast cancers
por: Secreto, Giorgio, et al.
Publicado: (2012)

Oestrogen receptor status and the response of human breast cancer cell lines to a combination of methotrexate and 17-beta oestradiol.
por: Clarke, R., et al.
Publicado: (1985)

Serum Oestradiol-17β in Women with Benign and Malignant Breast Disease
por: England, P. C., et al.
Publicado: (1974)

Genome-Wide Association Study of Circulating Estradiol, Testosterone, and Sex Hormone-Binding Globulin in Postmenopausal Women
por: Prescott, Jennifer, et al.
Publicado: (2012)

Synchronous onset of oestradiol-17β secretion by Meishan conceptuses
por: Pickard, Amanda R, et al.
Publicado: (2003)

Resistance training reduced luteinising hormone levels in postmenopausal women in a substudy of a randomised controlled clinical trial: A clue to how resistance training reduced vasomotor symptoms
por: Nilsson, Sigrid, et al.
Publicado: (2022)

Luteinising hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline
por: Yates, C, et al.
Publicado: (2005)

Testosterone, prolactin, and oncogenic regulation of the prostate gland. A new concept: Testosterone-independent malignancy is the development of prolactin-dependent malignancy!
por: Costello, Leslie C., et al.
Publicado: (2018)

Tamoxifen, 17beta-oestradiol and the calmodulin antagonist J8 inhibit human melanoma cell invasion through fibronectin.
por: Dewhurst, L. O., et al.
Publicado: (1997)

5-En-androstene-3 beta,17 beta-diol inhibits the growth of MCF-7 breast cancer cells when oestrogen receptors are blocked by oestradiol.
por: Boccuzzi, G., et al.
Publicado: (1994)

Effects of 17β-oestradiol on rat detrusor smooth muscle contractility
por: Valeri, Aurora, et al.
Publicado: (2009)

Effect of 17 beta-oestradiol on growth curves and flow cytometric DNA distribution of two human breast carcinomas grown in nude mice.
por: Brünner, N., et al.
Publicado: (1983)

Prolactin: The Third Hormone in Breast Cancer
por: Schuler, Linda A., et al.
Publicado: (2022)

Serum oestradiol levels are inversely associated with C-reactive protein levels in premenopausal women, but not postmenopausal women
por: Park, Jae-Min, et al.
Publicado: (2020)

Fractalkine is expressed in the human ovary and increases progesterone biosynthesis in human luteinised granulosa cells
por: Huang, Shuo, et al.
Publicado: (2011)

The Curious Case of Prolactin Hormone
por: Rohatgi, Shaurya, et al.
Publicado: (2015)

Diagnostic Performance of Anti-Müllerian Hormone, Luteinizing Hormone to Follicle-Stimulating Hormone Ratio, Testosterone, and Prolactin to Predict Polycystic Ovary Syndrome Among Sudanese Women
por: Alhassan, Samia, et al.
Publicado: (2023)

Field study assessing the performance of a patient-side blood test to determine neuter status in female cats based on detection of luteinising hormone
por: Morrow, Lisa D, et al.
Publicado: (2018)

Circulating levels of prolactin in human breast cancer.
por: Sheth, N. A., et al.
Publicado: (1975)

Non-protein bound oestradiol, sex hormone binding globulin, breast cancer and breast cancer risk.
por: Bruning, P. F., et al.
Publicado: (1985)

Gender differences in response to chronic treatment with 17β-oestradiol and 17β-aminoestrogen pentolame on hemostasis in rats
por: Lemini, Cristina, et al.
Publicado: (2012)

Serum oestradiol in women with and without breast disease.
por: Bennett, I. C., et al.
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_llabr40h6vtpe5ino6kf5u2ih6